Active substances
Clioquinol + Flumethasone pivalate
- Health Canada 2
- UK MHRA 2
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| LOCACORTEN VIOFORM | 00074462 | 3 % / W/W; 0.02 % / W/W | CREAM · TOPICAL | KNIGHT THERAPEUTICS INC. |
| LOCACORTEN VIOFORM EARDROPS | 00074454 | 0.02 % / W/V; 1 % / W/V | DROPS · OTIC | KNIGHT THERAPEUTICS INC. |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| FLUMETASONE/CLIOQUINOL 0.02% W/V / 1% W/V EAR DROPS SOLUTION | PL 20072/0012 | AMDIPHARM UK LIMITED | POM |
| LOCORTEN-VIOFORM EAR DROPS | PL 20072/0012 | AMDIPHARM UK LIMITED | POM |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.